com. A
replay of the Conference Call will be available approximately one hour after
the conclusion of the call by dialing 1-800-723-0532 (US) or 402-220-2655
(International) and will be archived until Thursday, May 12, 2005.

About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis.

photographs health

m. SAN DIEGO, Biosite Incorporated
(Nasdaq: BSTE) today announced that Kim Blickenstaff, chairman and chief
executive officer, and Ken Buechler, president and chief scientific officer,
will discuss the Company's operating environment, new and potential products
and the company's research and development activities at the 24th Annual JP
Morgan Healthcare Conference .m. Francis Hotel in San Francisco.

annual abstracts

) or 785-832-1508 (International) and using the
Conference ID# NBIX.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders. Information on
Biosite can be found at http: //www.

diseases conferences

Live Audio Webcast Wednesday, April 5, 2006

SAN DIEGO, Neurocrine Biosciences,
Inc.
Neurocrine Biosciences, Inc.

conference diego


If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at 858-617-7600 and ask for Claudia Woodworth or
Elizabeth Foster.neurocrine .

annual speakers

is a product-based biopharmaceutical Company
focused on neurological and endocrine diseases and disorders. Neurocrine Biosciences, Inc. The Biosite presentation will be archived on the
website until February 2, 2006 in the Investor and Media section under Events
Calendar.biosite.

fibrosis conference

biosite.

held disorders

photographs 2001

neurocrine .
(Nasdaq: NBIX) announced today that the Company will report first quarter 2005
financial results after the Nasdaq market closes Thursday, April 28, 2005.
Neurocrine will also host a live conference call and Webcast to discuss its
first quarter financial results and provide a Company update Thursday
afternoon, April 28, 2005 at 4:30 PM Eastern Daylight Time (EDT) / 1:30 PM
Pacific Daylight Time (PDT).neurocrine. The conference is to be
held at the Westin St.

san abstracts

Viewers are encouraged to visit the website approximately 5 minutes
prior to the presentation to download or install any necessary software. Management Will Also Provide Company Update

SAN DIEGO, Neurocrine Biosciences, Inc. Participants may access the live Conference Call
by dialing 1-800-905-0392 (U . Biosite's presentation will take place
Wednesday, January 11, 2006, at 8:00 a.

annual held

news releases are available
through the Company's website via the Internet at http://www.

Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2005 Financial Results

hospitals and in more than 50 international markets.

american conference

com


S.

list meetings

, (Nasdaq: NBIX) a biopharmaceutical company focused on neurological and
endocrine diseases and disorders announced today that Gary Lyons, President
and CEO will present at the CIBC Annual Biotechnology + Specialty
Pharmaceutical Conference Wednesday , April 5, 2006 at the Millennium Broadway
Hotel in New York.

photographs speakers

The presentation will be webcast
and can be accessed on the Company's website at http://www.
A replay of the webcast will be available approximately three hours after
the presentation concludes and will be archived until Wednesday, April 19,
2006.

2001 discuss


Pacific Time (PT) with Gary Lyons presenting an overview of the Company's
development pipeline and research programs.

american annual

m.com



A link to the live audio webcast can be accessed through the Biosite
website, http://www. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.

genetic discuss

Eastern Time (ET) / 8:30 a. The call can also be accessed via the Webcast through
the Company's website at http://www.

san annual

com or alternatively through a
link provided by PRNewswire at:
http://phx.corporate -ir.S.com.

Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated.

conference health

Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, irritable bowel syndrome,
and autoimmunity.

conferences speakers

semi annual

annual features

Neurocrine Biosciences to Present at the CIBC Annual Biotechnology + Specialty Pharmaceutical Conference


The live presentation begins at 11:30 a.neurocrine.net/phoenix.

Biosite Announces Presentation at the 24th Annual JP Morgan Healthcare Conference

Annual and semi-annual conferences and meetings to discuss Cystic Fibrosis.

photographs american

Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity. news releases are available through the Company 's
website via the Internet at http://www.com. The Company's logo is a trademark of
Biosite Incorporated .

photographs disorders

zhtml?p=irol-
eventDetails+c=68817+eventID=1058115

If you are unable to attend the Webcast and would like further information
on this announcement please contact Claudia Jones or Elizabeth Foster in the
Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Pacific .
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of
U.

meetings cystic



Neurocrine Biosciences, Inc.


san cystic

 You Are Here:  > Start > Health_and_Fitness > Conditions_and_Diseases > Genetic_Disorders > Cystic_Fibrosis > Conferences    ( Viewing: Main Section )
Working overtime to stay the Web's best reference!
Search the Web
 
-> Show SiteSeek's List of Web Sites For This Topic (Not Yet Peer Reviewed)

- -
kjjkjk


Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)